Y-PRIT
Live / Registered — Registered (as of 13 Aug 2024)
What this means for you
Registered since 13 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79377531
- Registration number
- 7470437
- Mark type
- Stylized text
- Filed
- 20 Jun 2023
- Published for opposition
- 28 May 2024
- Registered
- 13 Aug 2024
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer
- Class 042 — Scientific and technological services: Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technology services, namely, scientific research, testing and analysis in the field of antibodies and research and design services related thereto; industrial analysis services and industrial research services in the field of antibodies
Owner
- Y-mAbs Therapeutics, Inc, DE, US
- Y-mAbs Therapeutics, Inc, DE, US
- Y-mAbs Therapeutics, Inc, DE, US
Prosecution history
- 20 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 02 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 02 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 22 Feb 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 05 Feb 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 05 Feb 2025 — FINAL DISPOSITION PROCESSED
- 14 Nov 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 13 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 30 May 2024 — CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
- 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 May 2024 — PUBLISHED FOR OPPOSITION
- 08 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2024 — CORRECTION TRANSACTION RECEIVED FROM IB